Fino Payments Bank has received in-principle approval from the Reserve Bank of India to convert into a small finance bank.

Fino’s journey began in 2006 as a payments technology company and has played a pivotal role in India's financial inclusion ...

TOKYO -- Tech investor SoftBank Group remains focused on supporting OpenAI, Chief Financial Officer Yoshimitsu Goto told ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 8:30 AM ESTCompany ParticipantsJacqueline Shea - ...

Summary • Inovio Pharmaceuticals (INO) shares rose 8.02% in after-hours trading to $2.07 amid routine trading conditions.• ...

Precigen is a Buy after PAPZIMEOS' FDA approval and strong launch, with high pricing and growth potential. Click here to read ...

The stock market has been running high. Too high, some analysts say. A number of Wall Street observers warn the stock market may have entered “bubble” territory. It’s an analogy to the overhyped ...

The seemingly sturdy U.S. stock market has begun to wobble. Its months'-long tech-driven rally may be running out of steam amid growing wariness about the artificial intelligence boom and broader ...

What To Know: Warren Buffett’s Berkshire Hathaway reduced its stake in Apple, trimming its holdings by about 15% in the third quarter, according to an SEC filing from the well-regarded firm on Friday.

Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The S&P 500 is down 1.5% in afternoon trading. Bloom Energy stock is down much, much more, and on no obvious bad news. The reason: Valuation. Bloom Energy reported Q3 earnings last month, and the news ...

In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Inovio Pharmaceuticals, with a price target of $13.00. According to TipRanks, Singh is ranked #2884 out of 10072 ...